Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.
about
Assay of total plasma apolipoprotein B concentration in human subjectsAmino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complexMarked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-IThe isolation and partial characterization of the serum lipoproteins and apolipoproteins of the rainbow trout.Calorimetry of apolipoprotein-A1 binding to phosphatidylcholine-triolein-cholesterol emulsionsEvidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism.A study of the abnormal lipoproteins in abetalipoproteinemiaThe structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassayThe primary structure of high density apolipoprotein-glutamine-I13C nuclear magnetic resonance spectroscopic evidence for hydrophobic lipid-protein interactions in human high density lipoproteins.13C nuclear magnetic resonance spectroscopy of native and recombined lipoproteinsSerum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.Plasma lipoproteins after triglyceride clearance in cholesterol-fed rats.Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein.The lipoprotein abnormality in Tangier disease: quantitation of A apoproteinsTangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier)The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassayIsolation and characterization of an abnormal high density lipoprotein in Tangier DiesaseHigh density lipoprotein metabolism in man.Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondLipid-protein interactions in high density lipoproteinsApoprotein stability and lipid-protein interactions in human plasma high density lipoproteins.The location of apoprotein in plasma high-density lipoproteins: photochemical labelling studies.Characterization of serum lipoproteins of the shark Centrophorus squamous.Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay.Metabolism of apolipoproteins A-I and A-II and its influence on the high density lipoprotein subfraction distribution in males and females.Apolipoprotein C-III-1 activates lysosomal sphingomyelinase in vitro.A gel-based method for purification of apolipoprotein A-I from small volumes of plasma.Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activatorImmunological evidence for common antigenic sites in high-density lipoproteins from rainbow trout and man.Structure of human serum lipoproteins.Effect of disulfide cleavage on the molecular weight of one of the major polypeptides of human serum high density lipoprotein.
P2860
Q24300482-324FB7C0-01E7-4DCD-8865-10C0F2C02F39Q24563062-0B2FB449-85F8-442F-8630-2E45C4D66397Q28593920-FD40E53C-EF67-44F9-B82B-95972F93466FQ30633057-B48E56E3-A859-400A-B559-4567A55DF5F7Q34016970-E361019A-25A6-4064-BE6A-485698B89F4FQ34070635-0AFA211A-4C78-4802-B100-B9C27866770BQ34090099-2D786DF1-609B-4A6B-839B-92A5C94D3C91Q34461391-61A21B80-F192-4E34-AA31-0C7924456F3CQ34464375-94ACDB4B-3FBF-4468-B382-788F73885690Q35113395-87494EC4-ABD5-4B85-AD68-28594F2A07B3Q35113894-7F98C88B-F70D-4761-A6C8-3C13CDE90747Q35113932-84F82752-EB01-4582-A300-836B02C7E314Q35198844-08D57FB8-43B3-44A1-A3A4-C8D612E836FDQ35205168-7FD3B85E-E463-4221-B2F3-1A5781C98116Q35610557-86F588F8-D273-4E81-B508-91F78EF60608Q35897202-783DD11C-84A2-4AE2-A68F-D08004B27016Q35906192-459FBBFC-7AE8-4BC2-9852-BA5922505BA0Q36987421-3B91FC80-E048-4881-B9C4-3C4EF2B24D89Q37045345-83E54492-15EB-490A-868B-6A5D9A613792Q37045690-693BC399-D7DB-4D3D-8BAA-0181C8F715BDQ37047273-25AC57CD-EE8D-4031-A34A-1281DF94276AQ37162996-EDAEDA90-248C-422E-8516-CF72D01674AAQ37436115-A1D63E22-1B56-4637-B7E9-2CD978387895Q37464979-1458CDD3-2080-41AE-8189-C95CF26B5A3DQ40026682-CB9B21CB-2A45-41EC-BCF1-90AB8365C85DQ40082706-27EF379B-E27E-45DC-9C0E-CCFEE02AFF3AQ40158965-3CD6DE85-C99D-48CB-99B0-B9DF1A4B9542Q40171034-A0D066C2-C0EF-4342-8996-F8E96A3DA0EBQ40684618-AFBE343B-A603-4D4B-826F-7C7F57BC5BC6Q42127354-3E492057-D636-4598-9A2C-6584A3ACE88FQ42816842-961ED7A2-7634-4C3A-B810-AC2111F61214Q42817942-16DD3F3B-A752-411D-A73C-A3A97CFEB4F7Q45278422-4018D8FF-9A22-4F7E-956B-A259C5871D47Q47379267-9857CDBB-865F-449B-B5F0-14CCBA7787AA
P2860
Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Fractionation of human serum h ...... for polypeptide heterogeneity.
@en
Fractionation of human serum h ...... for polypeptide heterogeneity.
@nl
type
label
Fractionation of human serum h ...... for polypeptide heterogeneity.
@en
Fractionation of human serum h ...... for polypeptide heterogeneity.
@nl
prefLabel
Fractionation of human serum h ...... for polypeptide heterogeneity.
@en
Fractionation of human serum h ...... for polypeptide heterogeneity.
@nl
P2093
P356
P1433
P1476
Fractionation of human serum h ...... for polypeptide heterogeneity.
@en
P2093
P304
P356
10.1021/BI00836A027
P407
P577
1969-08-01T00:00:00Z